Habegger KM, Heppner KM, Geary N, Bartness TJ, DiMarchi R, Tschp MH
Global burden of 87 risk factors in 204 countries and territories, 19902019: a systematic analysis for the Global Burden of Disease study 2019
VanAntwerp also recommended observation on other possible underlying medical conditions
Nearly five in every 1,000 users of semaglutide drugs developed pancreatitis, compared to one of every 1,000 users of bupropion-naltrexone, the active ingredients in the weight-loss drug Contrave, according to a report in the JAMA medical journal
While waiting for potential FDA approval, focus on working with healthcare providers to explore currently available options